Integrating Digital Equity and Pragmatic Trials to Improve Cancer Screening and Care

The mHealth and Clinical Trials Research Affinity Groups present:

Integrating Digital Equity and Pragmatic Trials to Improve Cancer Screening and Care

Speaker:
Katharine A. Rendle, PhD, MSW, MPH
Deputy Director, Penn Center for Cancer Care Innovation
Assistant Professor, Department of Family Medicine & Community Health
University of Pennsylvania

About the speaker:
Katharine A. Rendle, PhD, MPH, MSW is an assistant professor of Family Medicine & Community Health and of Epidemiology in the Perelman School of Medicine at the University of Pennsylvania. She is also the deputy director of the Penn Center for Cancer Care Innovation (PC3I) at Abramson Cancer Center, and director of the Cancer Implementation Research at the Penn Implementation Science Center (PISCE@LDI).

Dr. Rendle leads a robust portfolio of NIH-funded research that integrates diverse quantitative and qualitative methods to improve the quality, equity, and implementation of cancer care delivery, with a substantial focus in cervical and lung cancer. Dr. Rendle earned her PhD in Anthropology and Social Work from the University of Michigan. She also earned her MPH in Epidemiology from the University of California, Berkeley, and completed her postdoctoral training at the National Cancer Institute's Cancer Prevention Fellowship.

About the talk:
Drawing from examples in cancer care delivery, we will discuss designing and implementing pragmatic trials and their potential to help reduce the research-to-practice gap in pediatric and adult oncology.

In this context, we will discuss different strategies for integrating, assessing, and advancing digital equity in pragmatic trials that use technology-supported strategies or are directly testing mHealth interventions. This talk will also discuss strategies for remaining nimble and pragmatic amid the rapidly changing landscape of technology.

Learning objectives:

• Provide foundational knowledge about designing pragmatic clinical trials in healthcare delivery and implementation science
• Identify strategies for integrating, assessing, and advancing digital equity in pragmatic trials
• Identify multilevel determinants of digital equity that should be considering in pragmatic trials and mHealth interventions